The gap between a 14.47x forward P/E and a negative trailing P/E suggests investors are pricing an expected swing back to profitability rather than valuing demonstrated earnings. The forward EV/EBITDA of 5.22x versus the trailing 20.26x implies EBITDA is expected to rise sharply, a projection that warrants close scrutiny given ten quarters of operating losses. Investors should monitor whether reported margin recovery materializes before treating the low P/S and P/B as evidence of value.

Gross margin has compressed from roughly 17% in mid-2024 to 6.9% now, indicating weakened pricing power or cost absorption rather than a temporary dip. Operating losses persist even as revenue has recently grown, which suggests top-line expansion is not yet producing operating leverage. The most recent quarter's net loss exceeding the operating loss points to non-operating drags that warrant further investigation.

Persistently negative ROIC suggests invested capital is not generating returns above its cost, consistent with the cumulative operating losses visible across the period. The return profile appears driven by weak margins rather than asset turnover, since asset turnover remains near 0.23x to 0.29x. Improvement would likely require sustained margin repair before capital efficiency can be meaningfully assessed.

Total debt has held in a narrow band near $200M while equity has swung widely, so leverage ratios are driven more by equity volatility than by borrowing changes. Negative interest coverage in the latest quarter suggests debt service is not currently supported by operating earnings, though coverage has oscillated between positive and negative values. Investors should monitor refinancing timing and whether operating income can turn sustainably positive relative to interest costs.